Leonteq Securities AG Makes New Investment in Bath & Body Works, Inc. $BBWI

Leonteq Securities AG bought a new position in Bath & Body Works, Inc. (NYSE:BBWIFree Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 36,408 shares of the company’s stock, valued at approximately $731,000.

A number of other institutional investors have also recently added to or reduced their stakes in BBWI. Royal Bank of Canada lifted its position in Bath & Body Works by 92.8% in the first quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock worth $1,815,000 after purchasing an additional 28,815 shares during the period. Goldman Sachs Group Inc. lifted its position in Bath & Body Works by 15.7% in the first quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock worth $19,586,000 after purchasing an additional 87,529 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Bath & Body Works by 7.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock worth $17,063,000 after purchasing an additional 36,684 shares during the period. Intech Investment Management LLC acquired a new stake in Bath & Body Works in the first quarter worth approximately $1,155,000. Finally, Geneos Wealth Management Inc. lifted its position in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on BBWI shares. Piper Sandler started coverage on Bath & Body Works in a research report on Friday, May 15th. They set a “neutral” rating and a $20.00 price objective for the company. TD Cowen cut their price objective on Bath & Body Works from $26.00 to $20.00 and set a “buy” rating for the company in a research report on Monday. Barclays increased their price objective on Bath & Body Works from $20.00 to $21.00 and gave the company an “equal weight” rating in a research report on Monday, March 2nd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Bath & Body Works in a research report on Monday, April 20th. Finally, UBS Group cut their price objective on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday. Three research analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the stock. Based on data from MarketBeat, Bath & Body Works presently has a consensus rating of “Hold” and a consensus target price of $21.21.

Read Our Latest Stock Analysis on BBWI

Bath & Body Works Stock Up 2.4%

BBWI opened at $17.74 on Friday. The stock has a fifty day moving average of $18.72 and a 200-day moving average of $20.37. The firm has a market capitalization of $3.57 billion, a P/E ratio of 5.63, a PEG ratio of 1.72 and a beta of 1.43. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $33.96.

Bath & Body Works (NYSE:BBWIGet Free Report) last released its earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.77 by $0.28. The company had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.59 billion. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The company’s revenue for the quarter was down 2.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.09 earnings per share. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, analysts expect that Bath & Body Works, Inc. will post 2.61 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 19th. Stockholders of record on Friday, June 5th will be issued a $0.20 dividend. The ex-dividend date is Friday, June 5th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.5%. Bath & Body Works’s dividend payout ratio is presently 25.40%.

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Featured Articles

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.